Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan

Genes and Immunity

Volumn 11, Issue 1, 2010, Pages 87-93

  Huang, Y W ^a,b   Liao, Y T ^c   Chen, W ^b   Chen, C L ^d   Hu, J T ^a,e   Liu, C J ^b,d   Lai, M Y ^b,d   Chen, P J ^b,d   Chen, D S ^b,d   Yang, S S ^a,e   Kao, J H ^b,d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Chronic carrier; Hepatitis B virus; Hepatocellular carcinoma; Polymorphism; Vitamin D receptor

Indexed keywords

HEPATITIS B(E) ANTIGEN; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; TAIWAN; VIRUS CARRIER;

HEPATITIS B VIRUS;

EID: 84984555556     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.65     Document Type: Article

References (39)

1. Lee W. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
2. Kao JH, Chen DS. Overview of hepatitis B and C viruses. In: Goedert JJ (ed). Infectious Causes of Cancer: Targets for Intervention. Humana Press Inc.: Totowa, 2000: 313-330.
3. Wasley A, Miller JT, Finelli L, CDC. Surveillance for acute viral hepatitis\-United States, 2005. MMWR. Surveillance Summaries 2007; 56: 1-24.
4. McQuillan GM, Townsend TR, Fields HA, Carrol M, Leahy M, Polk BF. Seroepidemiology of hepatitis B virus infection in the United States. Am J Med 1989; 87(suppl 3A): 5S-10S.
5. CDC. Hepatitis B virus: a comprehensive strategy for limiting transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40: RR-13:1-RR-13:25.
6. Hann HW, Hann RS, Maddrey WC. Hepatitis B virus infection in 6130 unvaccinated Korean-Americans surveyed between 1988 and 1990. Am J Gastroenterol 2007; 102: 767-772.
7. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262: 369-370.
8. Lin KW, Kirchner JT. Hepatitis B. Am Fam Physician 2004; 69: 75-82.
9. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472-1477.
10. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-774.
11. Huo T, Wu JC, Hwang SJ, Lai CR, Lee PC, Tsay SH et al. Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study. Eur J Gastroenterol Hepatol 2000; 12: 687-693.
12. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol 1994; 21: 656-666.
13. Forzani B, Actis GC, Verme G, Amoroso A, Borelli I, Curtoni ES et al. HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infection. Hepatology 1984; 4: 1107-1110.
14. Hattum JV, Schreuder GT, Schalm SW. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 1987; 7: 11-14.
15. Huang YW, Hu CY, Chen CL, Liao YT, Liu CJ, Lai MY et al. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus. J Med Virol 2009; 81: 588-593.
16. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13: 325-349.
17. Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143-156.
18. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys 2000; 374: 334-338.
19. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Thursz M, Whittle HC et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724.
20. Pourgholami MH, Akhter J, Ku Y, Morris DL. In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxy-vitamin D3. Cancer Lett 2000; 151: 97-102.
21. Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 2002; 40: 1207-1209.
22. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
23. Kao JH, Chen PJ, Lai MY, Chen DS. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus. Hepatology 2001; 34: 817-823.
24. Riggs BL, Nguyen TV, Melton III LJ, Morrison NA, O'Fallon WM, Kelly PJ et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995; 10: 991-996.
25. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004; 41: 659-666.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
27. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15(Suppl): E25-E30.
28. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up. Hepatology 2007; 45: 1187-1192.
29. Chu CM, Liaw YF. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 2007; 133: 1458-1465.
30. Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 2004; 116: 829-834.
31. Shiffman ML, Stewart CA, Hofmann CM, Contos MJ, Luketic VA, Sterling RK et al. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy. J Infect Dis 2000; 182: 1595-1601.
32. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S. Association between vitamin D receptor, CCR5, TNF-a and TNF-b gene polymorphisms and HBV infection and severity of liver disease. J Hepatol 2006; 44: 856-863.
33. Li JH, Chen DM, Li Z, Liu Y, Gao JR, Zeng XJ et al. Study on association between vitamin D receptor gene polymorphisms and the outcomes of HBV infection. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006; 23: 402-405. (Pubitemid 44272022)
34. Li JH, Li HQ, Li Z, Liu Y, Gao JR, Zeng XJ et al. Association of TaqI T/C and FokI C/T polymorphisms of vitamin D receptor gene with outcome of hepatitis B virus infection. Zhonghua Yi Xue Za Zhi 2006; 86: 1952-1956.
35. Lok ASF, McMahon BJ. AASLD practice guidelines. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
36. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371: 1-12.
37. Potter DM. A permutation test for inference in logistic regression with small-and moderate-sized data sets. Stat Med 2005; 24: 693-708.
38. Pourgholami MH, Morris DL. 1,25-dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies. J Steroid Biochem Mol Biol 2004; 89-90: 513-518.
39. Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg KJ, Lofts FJ et al. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 2003; 89: 252-257.